A Phase II trial investigating the use of umbilical cord blood mesenchymal stem cells (MSCs) to treat bronchopulmonary dysplasia (BPD) in premature infants has shown promising initial results, giving way to a larger Phase II study, focusing on a subset of babies who...
Researchers at Kyoto University’s Centre for iPS Cell Research and Application in Japan are moving ahead with the world’s first application of induced pluripotent stem cells (iPSCs) to treat Parkinson’s disease. The team, led by neurosurgeon Jun Takahashi, will now...
According to new research, an injection of cells from the placenta can ease the pain and other symptoms of arthritis sufferers for up to one year. The new treatment, ReNu, developed by British-US-based firm Organogensis, is made from cells of the innermost layer of...
A small study using umbilical cord blood stem cells to treat COVID-19 suggests that these stem cells could significantly improve survival rates and accelerate recovery time for critically ill COVID-19 patients. The study recently published in Stem Cells Translational...
2020 has been a difficult year. But the unprecedented challenges posed by the COVID-19 pandemic have also helped drive huge leaps forward in medical science. We’ve taken some time to reflect and summarise some of the significant advancements that have been made in the...
Initial data from early clinical trials show that mesenchymal stem cells could potentially stop the virus, calm the immune response and repair tissue damage caused by COVID-19. As the pandemic continues, the race is truly on to find an effective treatment for...
